Screener
Ironwood Pharmaceuticals IRWD Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies | ||
| Stockholders’ deficit: | ||
| Preferred stock, $0.001 par value, 75,000,000 shares authorized, no shares issued and outstanding | — | — |
| Class A Common Stock, $0.001 par value, 500,000,000 shares authorized; 165,239,947 shares issued and outstanding as of June 30, 2026 and 163,058,316 shares issued and outstanding as of December 31, 2025 | 165 | 163 |
| Additional paid-in capital | 1,419,970 | 1,412,780 |
| Accumulated deficit | (1,581,654) | (1,673,718) |
| Accumulated other comprehensive loss | (324) | (1,060) |
| Total stockholders’ deficit | (161,843) | (261,835) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ironwood Pharmaceuticals's common stock?
- Ironwood Pharmaceuticals (IRWD) reported common stock of $165K in Q2 2026.
- How has Ironwood Pharmaceuticals's common stock changed year-over-year?
- Ironwood Pharmaceuticals's common stock increased by 1.9% year-over-year, from $162K to $165K.
- What is the long-term trend for Ironwood Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's common stock has grown at a 0.2% compound annual growth rate (CAGR), from $161K to $163K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Ironwood Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude